刺
化学
癌症研究
兴奋剂
免疫疗法
癌症免疫疗法
免疫系统
背向效应
肿瘤微环境
信号转导
免疫原性细胞死亡
肉瘤
肿瘤浸润淋巴细胞
干扰素基因刺激剂
T细胞
癌症
瘢痕疙瘩
光动力疗法
受体
药理学
化学免疫疗法
免疫检查点
作者
Lili Yao,Sixin Li,Xiaohe Zhang,Youkang Zhai,Jiaping Shen,Chao Deng,Wenhai Lin,Shengliang Li,Zhiyuan Zhong
摘要
Reversing the immunosuppressive tumor microenvironment (ITME) is a crucial obstacle in the immunotherapy of cold tumor. The STING signaling pathway has shown promise in overcoming the ITME issue. However, reversing ITME via precise activation of the STING signaling pathway remains a significant challenge. In this work, photoresponsive nanophotocages with photoimmunogenic performance were developed for ITME-reversed synergistic photoimmunotherapy of cold tumor. In the photocage design, photoresponsive boron dipyrromethene (BODIPY) was used to link a STING agonist (DMXAA) and then prepared into water-dispersible nanoparticles. The iodinated nanophotocage showed the best photoreaction efficiency and spatiotemporal controllability among the four nanophotocages. Under light irradiation, the iodinated nanophotocages precisely released the STING agonist and triggered immunogenic cell death (ICD) via the photodynamic therapy (PDT) effect, by which the ITME was reversed to enhance the immune checkpoint inhibitor (aCTLA4) immunotherapy. The robust immune response not only achieved primary tumor eradication in 80% of the mice but also significantly inhibited the distant tumor. This work offers a photoimmunogenic photocage for light-controlled STING activation for ITME-reversed cancer photoimmunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI